Ricin: A toxic protein
From Proteopedia
(13 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | ==Background== | + | ==Background== |
- | Ricin is a toxin protein found in castor beans and the seeds of the castor oil plant. This heterodimeric protein is produced as a part of the waste that comes from the production of castor oil. Ricin was discovered more than a century ago when the protein was isolated from seeds by Stillmark. The protein is considered toxic due to its observed ability to clump up red blood cells. Later studies showed that ricin was a mixture of the potent cytotoxin and hemagglutinin. Such mechanism of the ricin was discovered on 28S ribosomal RNA. Since then, several functionally related proteins have been discovered from different plants. Such proteins are referred to as ribosome-inactivating proteins due to their ability to irreversibly inactivate eukaryotic ribosomes and terminating protein synthesis. Certain types of ricin known as ‘type I Ricins’ have toxic characteristics however it is seen that they do not have the capability to enter cells in order to reach the ribosomes. Other types are known as ‘type II Ricin’ however, have the capability to enter the cells due to their differences in structures. | + | [[Image:Castor beans1.jpeg|thumb|Ricin is produced in the Castor seeds of castor oil plant. Source:Wikepedia]] |
+ | '''Ricin''' is a toxin protein found in castor beans and the seeds of the castor oil plant. This heterodimeric protein is produced as a part of the waste that comes from the production of castor oil. Ricin was discovered more than a century ago when the protein was isolated from seeds by Stillmark. The protein is considered toxic due to its observed ability to clump up red blood cells. Later studies showed that ricin was a mixture of the potent cytotoxin and hemagglutinin. Such mechanism of the ricin was discovered on 28S ribosomal RNA. Since then, several functionally related proteins have been discovered from different plants. Such proteins are referred to as ribosome-inactivating proteins due to their ability to irreversibly inactivate eukaryotic ribosomes and terminating protein synthesis. Certain types of ricin known as ‘type I Ricins’ have toxic characteristics however it is seen that they do not have the capability to enter cells in order to reach the ribosomes. Other types are known as ‘type II Ricin’ however, have the capability to enter the cells due to their differences in structures. | ||
+ | |||
+ | <StructureSection load='' size='350' side='right' caption='' scene='88/882145/Ricin/4'> | ||
===Structure=== | ===Structure=== | ||
- | <scene name='88/882145/Ricin/4'>Type I Ricin</scene> only consists of the A-chain whereas <scene name='88/882145/Ricin/8'>Type II Ricin</scene> is comprised of the <scene name='88/882145/Ricin/13'>A-chain</scene> and the <scene name='88/882145/Ricin/ | + | <scene name='88/882145/Ricin/4'>Type I Ricin</scene> only consists of the A-chain whereas <scene name='88/882145/Ricin/8'>Type II Ricin</scene> is comprised of the <scene name='88/882145/Ricin/13'>A-chain</scene> and the <scene name='88/882145/Ricin/14'>B-chain</scene> which are folded peptide chains, with the two chains linked by <scene name='88/882145/Ricin/15'>disulfide bonds</scene>. Ricin has a molecular weight of 64-63 kDa, with the A-chain being 32 kDa and the B-chain being 36 kDa. The A-chain has the conformation of a globular protein domain with 267 amino acids consisting of 8 alpha-helices and 8 beta-sheets with the active site as a long cleft on its surface. The active site consists of a key catalytic residue Glutamic acid 177 which is deprotonated to glutamate reducing the activity immensely. Whereas the B-chain has the conformation of a barbell structure consisting of 26 amino acids, with a sugar-binding site at each end which allows it to hydrogen bond to galactose and N-acetyl galactosamine that is found on cell surfaces. The B-chain and the A-chain respectively do not cause the ricin to be toxic, Ricin’s toxicity is due to the presence of both chains because of their crucial roles together. The B-chain’s role is to acquire entry into eukaryotic cells, meanwhile, the A-chain is responsible for the toxicity because of its RNA N-glycosidase activity. Once the molecule enters the cell, the B-chain dissociates from the A-chain leaving it to exert its toxicity. |
- | + | ||
===Biosynthesis=== | ===Biosynthesis=== | ||
Line 13: | Line 16: | ||
===Ribosome inactivation=== | ===Ribosome inactivation=== | ||
- | As mentioned previously, Ricin’s A-chain has an rRNA N-glycosylase activity. This activity causes the cleavage of a glycosylic bond of the 60S ribosomes within the rRNA. The A-chain specifically and reversibly hydrolyzes the N-glycosidic bond of Adenine at position 4324 in the 28S rRNA however it leaves the backbone of the RNA intact. This target adenine at position 4324 (A4324) is in a highly conserved sequence of 12 universal nucleotides found in eukaryotic ribosomes. This highly conserved sequence is referred to as the Sarcin-ricin loop (SRL), it exists as an autonomous unit on the ribosome and exposed to the solvent. It has this unique feature in order for the loop to be accessible to external factors. The Sarcin-ricin loop is structured like a hairpin, it has basic organized elements including the GAGA loop which is where the ricin target adenine resides. Studies have shown that SRL is required for recruiting different elements responsible for translation elongation (translational GTPases) however it is seen that the loop has also been a target for many toxins. After the cleavage of the adenine residue from the loop, the RNA chain is left open to hydrolysis or even cleavage by other cellular lyases. Due to the function of the loop, any small disruption could lead to major effects on protein synthesis like inhibition, and eventually, when protein synthesis is inhibited, cell death. It is seen that a single molecule of ricin could inactivate over 1000 ribosomes per minute. | + | As mentioned previously, Ricin’s A-chain has an rRNA N-glycosylase activity. This activity causes the cleavage of a glycosylic bond of the 60S ribosomes within the rRNA. The A-chain specifically and reversibly hydrolyzes the N-glycosidic bond of Adenine at position 4324 in the 28S rRNA however it leaves the backbone of the RNA intact. This target adenine at position 4324 (A4324) is in a highly conserved sequence of 12 universal nucleotides found in eukaryotic ribosomes. This highly conserved sequence is referred to as the <scene name='88/882145/Sarcin-ricin-loop/2'>Sarcin-ricin loop</scene> (SRL), it exists as an autonomous unit on the ribosome and exposed to the solvent. It has this unique feature in order for the loop to be accessible to external factors. The Sarcin-ricin loop is structured like a hairpin, it has basic organized elements including the <scene name='88/882145/Sarcin-ricin-loop/3'>GAGA loop</scene> which is where the ricin target adenine resides. Studies have shown that SRL is required for recruiting different elements responsible for translation elongation (translational GTPases) however it is seen that the loop has also been a target for many toxins. After the cleavage of the adenine residue from the loop, the RNA chain is left open to hydrolysis or even cleavage by other cellular lyases. Due to the function of the loop, any small disruption could lead to major effects on protein synthesis like inhibition, and eventually, when protein synthesis is inhibited, cell death. It is seen that a single molecule of ricin could inactivate over 1000 ribosomes per minute. |
+ | </StructureSection> | ||
+ | ===Uses of Ricin=== | ||
+ | Unfortunately, ricin has been used as a biological agent numerous times, it is considered as a “Category B bioterrorism agent” and a “Schedule number 1 chemical warfare agent”. Despite its negative use, there have been studies done to potentially use it for some good. Ricin and other plant toxins have been studied for potential use in cancer therapy. It is hypothesized that ricin can be used to promote cell death in cancer cells. It is said that ricin could have great potential as an anti-cancer agent due to its ability to inhibit protein synthesis which eventually leads to apoptosis of the cell. | ||
+ | |||
+ | == See also == | ||
+ | [[Ricin]] | ||
+ | |||
+ | [[Toxins]] | ||
- | </StructureSection> | ||
== References == | == References == | ||
- | + | - Lord, J. Michael, and Lynne M. Roberts. “Ricin: Structure, mode of action, and some current applications.” Research Gate, 1994, https://www.researchgate.net/publication/15078743_Ricin_Structure_mode_of_action_and_some_current_applications. | |
+ | |||
+ | - Dorsey, Russel. “Ricin.” ScienceDirect, no. Handbook of Toxicology of Chemical Warfare Agents (Second Edition), 2015. https://www.sciencedirect.com/topics/neuroscience/ricin. | ||
+ | |||
+ | -Lord, J. Michael, and Robert A. Spooner. “Ricin Trafficking in Plant and Mammalian Cells.” NCBI, 2011. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202855/. | ||
+ | |||
+ | -Endo, Yaeta, and Kunio Tsurugi. “RNA N-Glycosidase Activity of Ricin A-chain.” THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 262, No.17, 1987, https://www.jbc.org/article/S0021-9258(18)47538-2/pdf. | ||
+ | |||
+ | -Przemyslaw, Grela. “How Ricin Damages the Ribosome.” MDPI, vol. 11, no. 5, 2019. https://www.mdpi.com/2072-6651/11/5/241/htm. | ||
+ | |||
+ | -“Ricin: Epidemiological Overview for Clinicians.” cdc, CDC, 2018, https://emergency.cdc.gov/agent/ricin/clinicians/epidemiology.asp. | ||
+ | |||
+ | -Tyagi, Nikhil. “Potential therapeutic applications of plant toxin-ricin in cancer: Challenges and advances.” Research gate, 2015. Research gate, https://www.researchgate.net/publication/281644756_Potential_therapeutic_applications_of_plant_toxin-ricin_in_cancer_Challenges_and_advances. |
Current revision
Contents |
Background
Ricin is a toxin protein found in castor beans and the seeds of the castor oil plant. This heterodimeric protein is produced as a part of the waste that comes from the production of castor oil. Ricin was discovered more than a century ago when the protein was isolated from seeds by Stillmark. The protein is considered toxic due to its observed ability to clump up red blood cells. Later studies showed that ricin was a mixture of the potent cytotoxin and hemagglutinin. Such mechanism of the ricin was discovered on 28S ribosomal RNA. Since then, several functionally related proteins have been discovered from different plants. Such proteins are referred to as ribosome-inactivating proteins due to their ability to irreversibly inactivate eukaryotic ribosomes and terminating protein synthesis. Certain types of ricin known as ‘type I Ricins’ have toxic characteristics however it is seen that they do not have the capability to enter cells in order to reach the ribosomes. Other types are known as ‘type II Ricin’ however, have the capability to enter the cells due to their differences in structures.
|
Uses of Ricin
Unfortunately, ricin has been used as a biological agent numerous times, it is considered as a “Category B bioterrorism agent” and a “Schedule number 1 chemical warfare agent”. Despite its negative use, there have been studies done to potentially use it for some good. Ricin and other plant toxins have been studied for potential use in cancer therapy. It is hypothesized that ricin can be used to promote cell death in cancer cells. It is said that ricin could have great potential as an anti-cancer agent due to its ability to inhibit protein synthesis which eventually leads to apoptosis of the cell.
See also
References
- Lord, J. Michael, and Lynne M. Roberts. “Ricin: Structure, mode of action, and some current applications.” Research Gate, 1994, https://www.researchgate.net/publication/15078743_Ricin_Structure_mode_of_action_and_some_current_applications.
- Dorsey, Russel. “Ricin.” ScienceDirect, no. Handbook of Toxicology of Chemical Warfare Agents (Second Edition), 2015. https://www.sciencedirect.com/topics/neuroscience/ricin.
-Lord, J. Michael, and Robert A. Spooner. “Ricin Trafficking in Plant and Mammalian Cells.” NCBI, 2011. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202855/.
-Endo, Yaeta, and Kunio Tsurugi. “RNA N-Glycosidase Activity of Ricin A-chain.” THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 262, No.17, 1987, https://www.jbc.org/article/S0021-9258(18)47538-2/pdf.
-Przemyslaw, Grela. “How Ricin Damages the Ribosome.” MDPI, vol. 11, no. 5, 2019. https://www.mdpi.com/2072-6651/11/5/241/htm.
-“Ricin: Epidemiological Overview for Clinicians.” cdc, CDC, 2018, https://emergency.cdc.gov/agent/ricin/clinicians/epidemiology.asp.
-Tyagi, Nikhil. “Potential therapeutic applications of plant toxin-ricin in cancer: Challenges and advances.” Research gate, 2015. Research gate, https://www.researchgate.net/publication/281644756_Potential_therapeutic_applications_of_plant_toxin-ricin_in_cancer_Challenges_and_advances.